Talk:Anti-thrombin aptamers

This article is within the scope of WikiProject Biophysics, a project which is currently considered to be inactive.BiophysicsWikipedia:WikiProject BiophysicsTemplate:WikiProject BiophysicsBiophysics articles

Molecular Biology C‑class Low‑importance

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the importance scale.

Wiki Education Foundation-supported course assignment[edit]

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Brianhero.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 17:25, 17 January 2022 (UTC)[reply]

Seems well out of date[edit]

Only has two references since 2011 - some idea of related clinical trials since then would be useful.
Is there a term for an aptamer conjugated to a payload (as with antibody-drug conjugate) ? - Rod57 (talk) 18:38, 19 February 2018 (UTC)[reply]